Regular articleBupropion SR and contingency management for adolescent smoking cessation
Keywords
Cited by (0)
Clinical Trials Registry: Combined Pharmaco/Behavior Therapy in Adolescent Smokers; NCT00330187; http://clinicaltrials.gov/ct2/show/study/NCT00330187.
Dr. Gray has received research support from Pfizer, Inc. (medication and placebo supply for research funded by the National Institute on Drug Abuse). Dr. Hartwell has received grant support through Global Research Awards for Nicotine Dependence, an independent competitive grants program supported by Pfizer, Inc. Dr. Hiott is a past speakers' bureau member of Bristol-Myers Squibb and Abbott Labs. Dr. Deas has been an advisory board and speakers' bureau member of Eli Lilly and Company. Dr. Upadhyaya is a past consultant and/or advisory board member of Eli Lilly and Company and Shire Pharmaceuticals. Dr. Upadhyaya is an ex-stockholder of New River Pharmaceutical Company, is a past speakers' bureau member of Shire Pharmaceuticals and Pfizer, Inc., and has received research support from Cephalon, Inc., Eli Lilly and Company, and Pfizer, Inc. Dr. Upadhyaya recently became an employee of, and is a holder of stock in, Eli Lilly and Company. The other investigators deny any potential conflicts of interest.